In 69 IBD patients (42 with MH and 27 with NMH) with normal CRP levels in our study, serum reg1α levels were significantly higher in the NMH group than in the MH group [77.4 (51.7–91.9) vs. 54.9 (36.8–78.0), p = 0.024, Figure 5(A)]. The gene discussed is REG1A; the disease is inflammatory bowel disease.